2026: $26,100 raised so far
HOOFING IT! 2026 Total so far $26,100
Start Hoofing It! Register now: join a team or start your own! Register Now
2025 Results Together we raised $40,662 — thank you to all 150 donors & 11 teams Donate Today
Why It Matters Every step funds NET research, drug access, & patient support across Canada Learn More
Sponsor a Walker Can’t walk? Sponsor a team member — every dollar counts Sponsor Now
2026 Total So Far $26,100 raised of $60,000 — keep on HOOFING IT! Donate Now
HOOFING IT! 2025:
Raised $40,662!

About cnetsadmin

This author has not yet filled in any details.
So far cnetsadmin has created 73 blog entries.

World NET Cancer Day a Success in Canada

On Friday, November 10th, 2017 – World NET Cancer Day, businesses and coffee shops around the world raised awareness about NETs using special coffee cups designed for the day. CNETS [...]

By |2018-05-07T18:28:10-04:00November 14th, 2017|Awareness|Comments Off on World NET Cancer Day a Success in Canada

Diagnostic Scan – Ga68

The Gallium 68 scan, used with functional PET imaging, is a nuclear medicine scan that relies on the over-expression of somatostatin receptors to visualize tumours. NETs typically express several somatostatin receptor subtypes in [...]

By |2018-05-07T18:28:11-04:00October 4th, 2017|Treatment News|Comments Off on Diagnostic Scan – Ga68

Somatuline (lanreotide) Access in Manitoba & Alberta

As we advised previously, in July of this year the Manitoba government issued a bulletin http://www.gov.mb.ca/health/mdbif/…/bulletins/bulletin93.pdf that indicated a change in the listing for Somatuline (from 1 to 3 and no access [...]

By |2018-05-07T18:28:11-04:00October 2nd, 2017|Treatment News|Comments Off on Somatuline (lanreotide) Access in Manitoba & Alberta

Caprelsa (vandetanib) for Medullary Thyroid NETs

Caprelsa is indicated for the treatment of symptomatic or progressive medullary thyroid cancer (MTC) in adult patients with unresectable locally advanced or metastatic disease.   An application for this drug was [...]

By |2018-05-07T18:28:11-04:00October 2nd, 2017|Treatment News|Comments Off on Caprelsa (vandetanib) for Medullary Thyroid NETs

Dr. Suzanne Richter

It is with profound sadness that we share the news of the passing of Dr. Suzanne Richter, Medical Oncologist on the NET team at London Health Sciences Centre.  This is [...]

By |2018-05-07T18:28:11-04:00April 4th, 2017|News|Comments Off on Dr. Suzanne Richter

Thank you

Thank you to all our donors and volunteers! As we start anew into 2017, CNETS Canada would like to acknowledge and thank all our donors and volunteers for their generosity. [...]

By |2018-05-07T18:28:11-04:00February 15th, 2017|News|Comments Off on Thank you

“LET’S TALK ABOUT NETs”

Media Advisory “LET’S TALK ABOUT NETs” Campaign Shines Spotlight on Rare Cancer Toronto, ON – October 27, 2016 – Between 12,000 to 15,000 Canadians are estimated to have a rare [...]

By |2018-05-07T18:28:12-04:00October 27th, 2016|Awareness, News|Comments Off on “LET’S TALK ABOUT NETs”
Go to Top